drugset / Trial / NCT04513340
WD-1603 PK Study Under Fasting and Fed Conditions in Healthy Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
The Phase 1 PK study is planned to evaluate the food effect on WD-1603 pharmacokinetics
Timeline
- Start
- 2020-08-13
- Primary completion
- 2020-09-05
- Completion
- 2021-02-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carbidopa | Unknown | 25 mg | Oral |
| Subject | Levodopa | Small molecule | 100 mg | Oral |